Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-005105
Filing Date
2018-01-24
Accepted
2018-01-24 16:21:16
Documents
1
Period of Report
2018-01-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1556
  Complete submission text file 0001209191-18-005105.txt   3050
Mailing Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618
Business Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618 949-419-0288
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 800 W. OLYMPIC BLVD SUITE 406 LOS ANGELES CA 90015
Business Address
Friedman Mark J (Reporting) CIK: 0001590024 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37752 | Film No.: 18545413